Andoy, Robella .

HRN: 17-28-16  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/13/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
02/13/2026
02/13/2026
IV
1 Gram
Single Dose
For CS
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Intra-abdominal    Compliance to guidelines: